Found: 5
Select item for more details and to access through your institution.
A Double-Blind Placebo Controlled Trial of Ginkgo biloba Added to Risperidone in Patients with Autistic Disorders.
- Published in:
- Child Psychiatry & Human Development, 2012, v. 43, n. 5, p. 674, doi. 10.1007/s10578-012-0292-3
- By:
- Publication type:
- Article
Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial.
- Published in:
- Psychopharmacology, 2011, v. 213, n. 4, p. 809, doi. 10.1007/s00213-010-2044-z
- By:
- Publication type:
- Article
A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease.
- Published in:
- Psychopharmacology, 2010, v. 207, n. 4, p. 637, doi. 10.1007/s00213-009-1706-1
- By:
- Publication type:
- Article
Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double-blind trial.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2010, v. 25, n. 7/8, p. 560, doi. 10.1002/hup.1154
- By:
- Publication type:
- Article
Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2010, v. 25, n. 7/8, p. 530, doi. 10.1002/hup.1148
- By:
- Publication type:
- Article